hypokalemic

A phase 3 trial of the drug dichlorphenamide in hyperkalemic and hypokalemic periodic paralysis is open at several U.S. and European centers

posted on October 14, 2011 - 10:13am
A multicenter study of the drug dichlorphenamide in 140 adults with hyperkalemic or hypokalemic periodic paralysis is open at sites in California, Kansas, Massachusetts, Minnesota, Missouri, New York, Ohio and Texas, as well as in France (not yet recruiting), Italy and the United Kingdom. 

New content is being added every day. Please check back again.